Cost and outcomes analysis of abciximab use in a community teaching hospital.
Abernathy
G B
GB
Inova Fairfax Hospital, Falls Church, VA 22042, USA.
Hewitt
K K
KK
D000077284:Abciximab; D000789:Angina, Unstable / Q000188:drug therapy; D015906:Angioplasty, Balloon, Coronary; D000911:Antibodies, Monoclonal / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D005260:Female; D017721:Hospital Costs; D006764:Hospitals, Community; D006784:Hospitals, Teaching; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000191:economics* / Q000627:therapeutic use; D008297:Male; D008499:Medical Records; D010359:Patient Readmission; D010975:Platelet Aggregation Inhibitors / Q000191:economics* / Q000627:therapeutic use; D012189:Retrospective Studies; D013927:Thrombosis / Q000517:prevention & control; D016896:Treatment Outcome; D014768:Virginia
D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D000077284:Abciximab